We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00040105
Recruitment Status : Completed
First Posted : June 21, 2002
Last Update Posted : August 1, 2012
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2009
  Study Completion Date : March 2009